Please try another search
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Malaysia. Its products include Caulerpa Lentillifera, a sea grape extract; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Cannabis Sativa, an industrial hemp. The company was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. BPH Global Ltd was incorporated in 1984 and is headquartered in Melbourne, Australia.
Name | Age | Since | Title |
---|---|---|---|
Matthew Leonard | - | 2023 | Executive Director |
Paul Stephenson | - | 2020 | Independent Non-Executive Chairman |
Theng Dar Teng | 72 | - | Advisor |
Alan Dronkers | - | 2020 | Strategic Advisor |
David Plattner | - | 2021 | Strategic Advisor |
Yanhua Huang | - | 2023 | Non-Executive Director |
Yee Chang | - | 2020 | Advisor |
Matthew Leonard | - | 2023 | MD & Executive Director |
Francesco Cannavo | - | 2021 | Part-Time Executive Director |
Huan Qing Gu | - | 2015 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review